Multiple protein kinases via activation of transcription factors NF-KB, AP-1 and C/EBP-5 regulate the IL-6/IL-8 production by HIV-1 Vpr in astrocytes

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Gangwani, Mohitkumar R ^a   Kumar, Anil ^a   Buch, Shilpa J ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN DELTA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR AP 1; VPR PROTEIN; CCAAT ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; ASTROCYTE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOHISTOCHEMISTRY; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS REPLICATION; CELL CULTURE; CELL LINE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ASTROCYTES; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; CELLS, CULTURED; GENE EXPRESSION REGULATION; GENE PRODUCTS, VPR; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; INTERLEUKIN-8; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

EID: 84943143765     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135633     Document Type: Article

References (54)

1. Kaul M, Garden GA, Lipton S.A. (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410: 988-994. PMID: 11309629
2. Crum NF, Riffenburgh RH, Wegner S, Agan B.K., Tasker SA, Spooner KM, et al. (2006) Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune DeficSyndr 41:194-200. PMID: 16394852
3. Heaton RK, Clifford DB, Franklin DR Jr., Woods S.P., Ake C, Vaida F, et al. (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75: 2087-2096. doi: 10.1212/WNL.0b013e318200d727 PMID: 21135382
4. Burdo TH, Lackner A, Williams KC (2013) Monocyte/macrophages and their role in HIV neuropathogenesis. Immunol Rev 254:102-113. doi: 10.1111/imr.12068 PMID: 23772617
5. Mattson MP, Haughey NJ, Nath A. (2005) Cell death in HIV dementia. Cell Death Differ 12 Suppl 1: 893-904. PMID: 15761472
6. Guha D, Nagilla P, Redinger C, Srinivasan A, Schatten GP, Ayyavoo V, et al. (2012) Neuronal apoptosis by HIV-1 Vpr: contribution of proinflammatory molecular networks from infected target cells. J Neuroinflammation 9:138. doi: 10.1186/1742-2094-9-138 PMID: 22727020
7. Li W, Galey D, Mattson M.P., Nath A. (2005) Molecular and cellular mechanisms of neuronal cell death in HIV dementia. NeurotoxRes 8:119-134. PMID: 16260390
8. Carroll-Anzinger D., Al-Harthi L (2006) Gamma interferon primes productive human immunodeficiency virus infection in astrocytes. J Virol 80: 541-544. PMID: 16352578
9. Popov S, Rexach M, Ratner L., Blobel G, Bukrinsky M. (1998) Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex. J BiolChem 273:13347-13352. PMID: 9582382
10. Mukerjee R, Chang JR, Del Valle L, Bagashev A, Gayed MM, Lyde RB, et al. (2011) Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. J BiolChem 286: 34976-34985. doi: 10.1074/jbc.M111.241547 PMID: 21816823
11. Patel CA, Mukhtar M, Pomerantz RJ (2000) Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells. J Virol 74: 9717-9726. PMID: 11000244
12. Thirumangalakudi L, Yin L, Rao H.V., Grammas P. (2007) IL-8 induces expression of matrix metalloproteinases, cell cycle and pro-apoptotic proteins, and cell death in cultured neurons. J Alzheimers Dis 11: 305-311. PMID: 17851181
13. Roux P, Alfieri C, Hrimech M., Cohen EA, Tanner J.E. (2000) Activation of transcription factors NF-kappaBand NF-IL-6 by human immunodeficiency virus type 1 protein R(Vpr) induces interleukin-8 expression. J Virol 74: 4658-4665. PMID: 10775602
14. Hoshino S, Konishi M, Mori M, Shimura M, Nishitani C, Kuroki Y, et al. (2010) HIV-1 Vpr induces TLR4/MyD88-mediated IL-6 production and reactivates viral production from latency. J Leukoc Biol 87: 1133-1143. doi: 10.1189/jlb.0809547 PMID: 20145198
15. Campbell IL, Abraham CR, Masliah E, Kemper P., Inglis JD, Oldstone MB, et al. (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A 90:10061-10065. PMID: 7694279
16. Ton H, Xiong H. (2013) Astrocyte Dysfunctions and HIV-1 Neurotoxicity. J AIDS Clin Res 4: 255. PMID: 24587966
17. Abbott NJ (2002) Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 200: 629-638. PMID: 12162730
18. Eugenin EA, Clements JE, Zink M.C., Berman J.W. (2011) Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism. J Neurosci 31: 9456-9465. doi: 10.1523/JNEUROSCI.1460-11.2011 PMID: 21715610
19. Farina C, Aloisi F, Meinl E. (2007) Astrocytes are active players in cerebral innate immunity. Trends Immunol 28: 138-145. PMID: 17276138
20. Ferrucci A, Nonnemacher MR, Wigdahl B. (2013) Extracellular HIV-1 viral protein R affects astrocytic glyceraldehyde 3-phosphate dehydrogenase activity and neuronal survival. J Neurovirol 19: 239-253. doi: 10.1007/s13365-013-0170-1 PMID: 23728617
21. Major EO, Miller AE, Mourrain P, Traub R.G., de Widt E, Sever J, et al (1985) Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc Natl Acad Sci U SA 82:1257-1261. PMID: 2983332
22. Gangwani MR, Noel RJ Jr., Shah A., Rivera-Amill V, Kumar A. (2013) Human immunodeficiency virus type 1 viral protein R (Vpr) induces CCL5 expression in astrocytes via PI3K and MAPK signaling pathways. J Neuroinflammation 10:136. doi: 10.1186/1742-2094-10-136 PMID: 24225433
23. Gardner J, Borgmann K, Deshpande M.S., Dhar A., Wu L, Persidsky R, et al (2006) Potential mechanisms for astrocyte-TIMP-1 downregulation in chronic inflammatory diseases. J Neurosci Res 83: 1281-1292. PMID: 16555295
24. Shah A, Verma AS, Patel KH, Noel R, Rivera-Amill V, Silverstein PS, et al. (2011) HIV-1 gp120 induces expression of IL-6 through a nuclear factor-kappa B-dependent mechanism: suppression by gp120 specific small interfering RNA. PLoSOne 6: e21261. doi: 10.1371/journal.pone.0021261 PMID: 21712995
25. Shah A, Kumar A. (2010) HIV-1 gp120-mediated increases in IL-8 production in astrocytes are mediated through the NF-kappaB pathway and can be silenced by gp120-specific siRNA. J Neuroinflammation 7: 96. doi: 10.1186/1742-2094-7-96 PMID: 21190575
26. Ganchi PA, Sun SC, Greene W.C., Ballard D.W. (1993) A novel NF-kappaB complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerization. Mol Cell Biol 13: 7826-7835. PMID: 8246997
27. Lee JC, Kassis S, Kumar S., Badger A, Adams J.L. (1999) p38 mitogen-activated protein kinase inhibitors - mechanisms and therapeutic potentials. Pharmacol Ther 82:389-397. PMID: 10454214
28. Messam CA, Major E.O. (2000) Stages of restricted HIV-1 infection in astrocyte cultures derived from human fetal brain tissue. J Neurovirol 6 Suppl 1: S90-94. PMID: 10871771
29. Trillo-Pazos G., Diamanturos A, Rislove L., Menza T, Chao W, Belem P, et al. (2003) Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol 13:144-154. PMID: 12744468
30. Davidson DC, Hirschman MP, Sun A, Singh M.V., Kasischke K., Maggirwar SB, et al. (2012) Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disorders. PLoSOne 7: e51793. doi: 10.1371/journal.pone.0051793 PMID: 23251626
31. Strazza M, Pirrone V, Wigdahl B., Nonnemacher M.R. (2011) Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain Res 1399: 96-115. doi: 10.1016/j.brainres.2011.05.015 PMID: 21641584
32. Levy DN, Refaeli Y, MacGregor R.R., Weiner D.B. (1994) Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 91:10873-10877. PMID: 7971975
33. Hoffmann E, Dittrich-Breiholz O, Holtmann H., Kracht M. (2002) Multiple control of interleukin-8 gene expression. J Leukoc Biol 72: 847-855. PMID: 12429706
34. Libermann TA, Baltimore D. (1990) Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 10: 2327-2334. PMID: 2183031
35. Liu R, Tan J, Lin Y., Jia R, Yang W, Liang C, et al. (2013) HIV-1 Vpr activates both canonical andnoncanonical NF-kappaB pathway by enhancing the phosphorylation of IKKalpha/beta. Virology 439: 47-56. doi: 10.1016/j.virol.2013.01.020 PMID: 23453579
36. Schmitz ML, Baeuerle P.A. (1991) The p65 subunit is responsible for the strong transcription activating potential of NF-kappaB. EMBOJ 10:3805-3817. PMID: 1935902
37. Madrid LV, Mayo MW, Reuther JY, Baldwin AS Jr. (2001) Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappaB through utilization of the IkappaB kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 276:18934-18940. PMID: 11259436
38. Shah A, Silverstein PS, Kumar S, Singh D.P., Kumar A. (2012) Synergistic cooperation between methamphetamine and HIV-1 gsp120 through the P13K/Akt pathway induces IL-6 but not IL-8 expression in astrocytes. PLoS One 7: e52060. doi: 10.1371/journal.pone.0052060 PMID: 23251686
39. Dong C, Davis RJ, Flavell R.A. (2002) MAP kinases in the immune response. Annu Rev Immunol 20: 55-72. PMID: 11861597
40. Holloway G, Coulson B.S. (2006) Rotavirus activates JNK and p38 signaling pathways in intestinal cells, leading to AP-1-driven transcriptional responses and enhanced virus replication. J Virol 80:10624-10633. PMID: 16928761
41. Das M, Garlick DS, Greiner DL, Davis RJ (2011) The role of JNK in the development of hepatocellular carcinoma. Genes Dev 25: 634-645. doi: 10.1101/gad.1989311 PMID: 21406557
42. Kondo A, Otsuka T, Matsushima-Nishiwaki R, Kuroyanagi G, Mizutani J, Wada I, et al. (2013) Inhibition of SAPK/JNK leads to enhanced IL-1-induced IL-6 synthesis in osteoblasts. Arch Biochem Biophys 535: 227-233. doi: 10.1016/j.abb.2013.04.007 PMID: 23624146
43. Piao CS, Che Y, Han P.L., Lee J.K. (2002) Delayed and differential induction of p38 MAPK isoforms in microglia and astrocytes in the brain after transient global ischemia. Brain Res Mol Brain Res 107: 137-144. PMID: 12425942
44. Kitatani K, Sheldon K, Anelli V., Jenkins RW, Sun Y, Grabowski GA, et al (2009) Acid beta-glucosidase 1 counteracts p38delta-dependent induction of interleukin-6: possible role for ceramide as an antiinflammatory lipid. J Biol Chem 284:12979-12988. doi: 10.1074/jbc.M809500200 PMID: 19279008
45. Grassl C, Luckow B, Schlondorff D, Dendorfer U. (1999) Transcriptional regulation of the interleukin-6 gene in mesangial cells. J AmSoc Nephrol 10:1466-1477. PMID: 10405202
46. Mukaida N, Okamoto S, Ishikawa Y, Matsushima K (1994) Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol 56: 554-558. PMID: 7525815
47. Hungness ES, Luo GJ, Pritts TA, Sun X, Robb BW, Hershko D, et al. (2002) Transcription factors C/EBP-betaand - delta regulate IL-6 production in IL-1beta-stimulated human enterocytes. J Cell Physiol 192: 64-70. PMID: 12115737
48. Valente T, Straccia M, Gresa-Arribas N, Dentesano G, Tusell JM, Serratosa J, et al. (2013) CCAAT/enhancer binding protein delta regulates glial proinflammatory gene expression. Neurobiol Aging 34: 2110-2124. doi: 10.1016/j.neurobiolaging.2013.02.007 PMID: 23523267
49. Yan C, Johnson PF, Tang H, Ye Y., Wu M, Gao H, et al (2013) CCAAT/enhancer-binding protein delta is a critical mediator of lipopolysaccharide-induced acute lung injury. Am J Pathol 182: 420-430. doi: 10.1016/j.ajpath.2012.10.013 PMID: 23177475
50. Kinoshita S, Akira S, Kishimoto T (1992) A member of the C/EBP family, NF-IL6beta, formsaheterodi-merandtranscriptionally synergizes with NF-IL6. Proc Natl Acad Sci USA 89:1473-1476. PMID: 1741402
51. Faggioli L, Costanzo C, Donadelli M, Palmieri M (2004) Activation of the Interleukin-6 promoter by a dominant negative mutant of c-Jun. Biochim BiophysActa 1692:17-24. PMID: 15158360
52. Duverger A, Wolschendorf F, Zhang M., Wagner F, Hatcher B, Jones J., et al. (2013) An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection. J Virol 87: 2264-2277. doi: 10.1128/JVI.01594-12 PMID: 23236059
53. Pereira LA, Bentley K, Peeters A, Churchill MJ, Deacon NJ (2000) A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res 28: 663-668. PMID: 10637316
54. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, et al. (1993) Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A 90:10193-10197. PMID: 8234276